<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ900807-0019</DOCNO><DOCID>900807-0019.</DOCID><HL>   International Brief -- Schering AG:   Earnings for the First Half   Rose 12% to $114.3 Million</HL><DATE>08/07/90</DATE><SO>WALL STREET JOURNAL (J), PAGE A12</SO><CO>   G.SCH</CO><IN>EARNINGS (ERN)</IN><LP>   Schering AG of West Germany, a pharmaceutical and chemicalcompany, said first-half profit rose 12% to 182 million marks($114.3 million) from 162 million marks a year earlier.   But sales, damped by strongly negative foreign currencytranslation factors, edged up just 0.8% to 3.22 billion marksfrom 3.19 billion marks.</LP><TEXT>   Buoyed by strong first-half profit growth, the companyupgraded its cautious estimate of flat full-year earnings,saying it expects an improvement.   Profit for the parent company, which includes domesticperformance and exports but excludes results of most foreignand some domestic units, rose 12% to 137 million marks from122 million marks. The parent's sales increased 4.4% to 1.69billion marks from 1.62 billion marks. Its sales abroad wereup 6.1% at 1.16 billion marks, compared with the year-earlier1.09 billion marks, and sales in West Germany rose 0.8% to530 million marks from 526 million marks. On a world-widegroup basis, including the parent's results, foreign saleswere flat at 2.537 billion marks.</TEXT></DOC>